J9223 HCPCS code: Injection, lurbinectedin, 0.1 mg
J9223 is the HCPCS Level II code for injection, lurbinectedin, 0.1 mg. In 2024 Medicare paid an average of $156.63 per service for J9223 across 193,969 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 120 per day on outpatient hospital claims. Medicare volume rose 2% from 2022 to 2024 (190,809 to 193,969 services). In 2024, about 845 clinicians billed Medicare for J9223 for 650 beneficiaries; Florida, Illinois, Tennessee accounted for 30% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2021-01-01 |
| Last action effective | 2021-01-01 |
Who bills J9223 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 845 |
| Medicare beneficiaries | 650 |
| States with claims | 21 |
| Share of services in top 3 states (Florida, Illinois, Tennessee) | 30% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9223, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 190,809 | 703 | $179.27 | $143.13 |
| 2023 | 195,511 | 684 | $186.93 | $148.94 |
| 2024 | 193,969 | 650 | $196.60 | $156.63 |
States with the most J9223 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 23,303 | $157.39 |
| Illinois | 13,463 | $157.54 |
| Tennessee | 12,640 | $151.22 |
| Texas | 11,449 | $155.21 |
| New York | 11,240 | $157.78 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 120 | CMS Policy |
| practitioner claims | 120 | CMS Policy |
What changed for J9223
- 2021-01-01: J9223 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9223?
J9223 is the HCPCS Level II code for injection, lurbinectedin, 0.1 mg. Short descriptor: "Inj. lurbinectedin, 0.1 mg".
How much does Medicare pay for J9223?
In 2024, the average Medicare payment was $156.63 per service (average allowed $196.60).
Does Medicare cover J9223?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9223 can be billed per day?
120 on outpatient hospital claims; 120 on practitioner claims (NCCI medically unlikely edits).
Related J92 codes
- J9200 — Injection, floxuridine, 500 mg
- J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202 — Goserelin acetate implant, per 3.6 mg
- J9203 — Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 — Injection, mogamulizumab-kpkc, 1 mg
- J9205 — Injection, irinotecan liposome, 1 mg
- J9206 — Injection, irinotecan, 20 mg
- J9207 — Injection, ixabepilone, 1 mg
- J9208 — Injection, ifosfamide, 1 gram
- J9209 — Injection, mesna, 200 mg
- J9210 — Injection, emapalumab-lzsg, 1 mg
- J9211 — Injection, idarubicin hydrochloride, 5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9223
- Watch J9223 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9223
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.